Navigation Links
US Proton Therapy Market Analysis to 2017
Date:10/21/2013

London (PRWEB) October 21, 2013

According to most Oncologists, about 60% of all cancer patients undergo some sort of radiation therapy during their course of treatment. Despite advances in technology for radiation therapy, a majority of these patients suffer from side effects of traditional radiation treatment. Currently prevalent radio therapy methods like X-Ray/IMRT etc. also cost pretty high in the long run.

In this context, Proton Therapy, the latest innovation in the field of radio-oncology, answers all the problems related to radiation therapy. The technology is expected to eventually replace the traditional methods of radiotherapy in the future and thus, holds immense market potential for players in the industry.

The report, “US Proton Therapy Market Analysis to 2017”, presented in 30 slides, provides an extensive research and in-depth analysis of the current status and future outlook of the US proton therapy market. A thorough analysis has been carried on the various parameters concerned with the existing and upcoming proton therapy centers in the US. The report offers state-wise potential for the industry players and provides conservative market estimates till 2017.

As per our research, Procure is the leading service provider and accounts for the major chunk of proton therapy market in the US. From an equipment provider’s perspective, IBA has the maximum proton accelerators installed in the facilities. The report further delves into the anticipated transformation into competitive landscape due to increase in number of players leading to highly competitive market. It also comes up with upcoming trends, such as kind of treatment room model, types of proton accelerators being installed, etc.

With core statistical information on proton therapy market, the research also provides a glimpse on the fundamental requirements for setting up a proton therapy center. It describes in detail about the different components and their role in proton therapy. The research also portrays the amount of investment required for establishing a proton therapy center based on different treatment room models.

The report, which is a result of comprehensive analysis of the market by RNCOS experts, clearly describes various aspects related to setting up a proton therapy center and also states the appropriate location for the same. Further, all important aspects of market like the current market size, forecasts, readymade account of all the players that are expected to enter the market along with various drivers, challenges, and trends are provided, making it a must read for Consultants and Companies in/planning to get in the market.

1. What is Proton Therapy?

2. Why is Proton Therapy Better than X-ray/IMRT?

3. Which Cancers Can be Treated?

4. How to Set-up a Proton Therapy Center?

4.1 What are the Different Components?

5. Proton Therapy Centers: US Market Scenario

5.1 Service and Equipment Providers: Existing Players
5.2 Service and Equipment Providers: Outlook 2017

6. Market Dynamics

6.1 Drivers and Challenges
6.2 Current and Expected Market Growth
6.3 Investment Required
6.4 Potential Customer Base by State Outlook 2017

7. US Proton Therapy Centers Future Direction

8. Market Opportunity Assessment

List of Figures:

Figure-1: Existing States with Proton Therapy Centers
Figure-2: Upcoming States with Proton Therapy Centers by 2017
Figure-3: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers, 2012
Figure-4: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers, 2017
Figure-5: Proton Therapy Market (Million US$), 2012-2017
Figure-6: Proton Therapy Market Penetration (%), 2012
Figure-7: Breakup of Investment Required to Set-up Proton Therapy Center (%)
Figure-8: Proton Therapy Centers by Number of Treatment Rooms (2012 & 2017)
Figure-9: Proton Therapy Centers by Number and Type of Accelerator (2012 & 2017)

List of Tables:

Table-1: Existing Proton Therapy Centers with Type of Installed Proton Accelerator
Table-2: Existing Equipment Providers with Number of Installations
Table-3: Upcoming Proton Therapy Centers with Type of Installed Proton Accelerator by 2017
Table-4: Upcoming Equipment Providers with Number of Installations by 2017
Table-5: State-wide Number of Potential Patients for Proton Therapy by 2017
Table-6: Top 10 States with Maximum Market Opportunity

Read the full report:

US Proton Therapy Market Analysis to 2017

http://www.reportbuyer.com/pharma_healthcare/biotechnology/us_proton_therapy_market_analysis_2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com

Read the full story at http://www.prweb.com/releases/2013/10/prweb11251007.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Intensity modulated proton therapy reduces need for feeding tubes by 50 percent
2. Penn Medicine study: Proton therapy cuts side effects for pediatric head and neck cancer patients
3. Horner Flooring to provide court for the MD Anderson Proton Therapy Showcase in Houston.
4. Proton therapy treatment preserves quality of life for men with prostate cancer
5. Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
6. Occupational Therapy Practitioners Offer Health Care Solutions on Capitol Hill
7. North American Seminars Introduces a New Physical Therapy Continuing Education Course Online, The Lymphedema Toolbox
8. Palm Beach Academy of Health and Beauty Offers Degrees in Skin Care, Massage Therapy and Much More
9. Hands On HealthCare Massage Therapy and Wellness Day Spa Concludes Fundraising and Raising Awareness of Childhood Cancer
10. North American Seminars Received Physical Therapy Course Approval for Continuing Education for Advanced Examination and Treatment for Selected Shoulder Conditions
11. North American Seminars Introduces a New Physical Therapy Continuing Education Course, Geriatric Pain and Mobility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® ... area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony ... Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ...
(Date:12/4/2016)... Washington DC (PRWEB) , ... December 04, 2016 , ... ... Environmental, one of the most certified and experienced Indoor Air Quality Companies in VA, ... Assessment and Remediation Regulations. , The new mold law in the district ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: